---
title: "SLC12A1"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Information on Gene SLC12A1"
tags: ['SLC12A1', 'Na-K-2ClCotransporter', 'BartterSyndrome', 'ElectrolyteBalance', 'Mutation', 'Treatment', 'Prognosis', 'DrugResponse']
---

# Information on Gene SLC12A1

## Genetic Position, Pathology, and Function

SLC12A1, also known as solute carrier family 12 member 1, is a gene located on chromosome 15q21 which encodes for the Na-K-2Cl cotransporter (NKCC2) protein. This protein plays a significant role in the renal reabsorption of sodium, potassium, and chloride ions, and the maintenance of electrolyte balance in the body. Mutations in the SLC12A1 gene have been linked to Bartter syndrome type 1, which is characterized by a loss of electrolytes in the urine, leading to metabolic alkalosis and increased renin and aldosterone secretion.

## Function for Gene:

The SLC12A1 gene encodes for the Na-K-2Cl cotransporter protein that is responsible for the reabsorption of sodium, potassium, and chloride ions by the kidneys. The protein plays a significant role in maintaining electrolyte balance in the body and regulates important physiological functions such as blood pressure, fluid balance, and acid-base balance.

## External IDs for Gene and Genomic Location, Aliases

- HGNC: 11035
- NCBI Entrez: 6557
- Ensembl: ENSG00000126309
- OMIM: 600839
- UniProtKB/Swiss-Prot: P55011
- Genomic Location: Chromosome 15q21

Aliases:
- BSC1
- BSND
- NKCC2

## AA Mutation List and Mutation Type with dbSNP ID

The SLC12A1 gene is known to have several missense, nonsense, insertion, and deletion mutations. Some of the commonly known mutations are:

| AA Mutation | Mutation Type | dbSNP ID |
| --- | --- | --- |
| L165P | Missense | rs137853234 |
| P187L | Missense | rs121908578 |
| E223G | Missense | rs137853236 |
| R324Q | Missense | rs111381378 |
| L437W | Missense | rs121908579 |

## Somatic SNVs/InDels with dbSNP ID

There are several somatic SNVs/Indels reported in the SLC12A1 gene. Some of the known mutations are:

| Mutation | dbSNP ID |
| --- | --- |
| c.857G>A | rs201725593 |
| c.1376_1385delGAGCCAGAAG | rs148858696 |
| c.1540_1542delATA | rs786203188 |
| c.2047dupA | rs751918244 |

## Related Disease

Mutations in the SLC12A1 gene have been linked to Bartter Syndrome Type 1 (BS1). This is an autosomal recessive disorder characterized by polyuria, hypokalemia, metabolic alkalosis, and increased secretion of renin and aldosterone. The symptoms of BS1 include muscle weakness, muscle cramps, fatigue, and delayed growth and development.

## Treatment and Prognosis

There is no curative treatment for Bartter syndrome. However, the treatment primarily involves the correction of electrolyte and fluid imbalances through medication, diet, and hormone therapy.

The prognosis in most cases of Bartter syndrome is generally favorable, and patients can lead a normal life with medical management.

## Drug Response

There is limited evidence on drug response for Bartter syndrome patients. However, some studies have shown that the use of nonsteroidal anti-inflammatory drugs (NSAIDs) may provide symptomatic relief for some patients.

## References

- Blanchard A et al. Mutation Update and Genotype-Phenotype Correlations of Novel and Previously Described Mutations in SLC12A1/2 Genes: Bartter Syndrome Type 1, Gitelman Syndrome and Other Salt-Losing Tubulopathies. Hum Mutat. 2021 Jul 12. doi: 10.1002/humu.24256. Epub ahead of print. PMID: 34251762.

- Fathallah-Shaykh S. Bartter Syndrome Type I. 2008 Mar 19 [Updated 2018 Jun 14]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. Available from: [Click](https://www.ncbi.nlm.nih.gov/books/NBK1372/.) PMID: 20301471.

- Simon DB, Karet FE, Hamdan JM, et al. Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2 DOI: 10.1038/35087000

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**